12 January 2018 | Press releases

Unitaid rated A+ for second year running by UK Department for International Development

Geneva – For the second year in a row, Unitaid has scored an A-plus rating in the UK’s Department for International Development’s (DFID) Annual Review, which sets rigorous performance standards for all projects that the UK financially supports.

DFID praised Unitaid’s “launch of a robust new strategy and key performance indicators (KPI) framework, and significant progress across a number of key organizational reform areas.”

The excellent rating underscored the important work Unitaid is doing to hasten access to innovative health products such as better and less expensive HIV treatment.

“Congratulations on this excellent score,” said Sarah Boulton, Vice Chair of the Executive Board. “Unitaid has met or exceeded expectations across each of the five Board-approved reform milestones.”

“We should be very proud,” said Lelio Marmora, Unitaid Executive Director. “The review encompasses every dimension of our performance. It places us among the strongest performing organizations funded by the UK government.”

The rating recognizes the staff’s work across all areas to build a stronger organization, Marmora said, including efforts to continuously improve risk management and value for money, and to deepen collaboration with health partners.

DFID leads the UK’s work to end extreme poverty, tackling global challenges including poverty and disease, mass migration, insecurity and conflict.

Unitaid is an international organization that invests in new ways to prevent, diagnose and treat HIV/AIDS, hepatitis C, tuberculosis and malaria more quickly, more affordably and more effectively. It accelerates access to innovation so critical health products reach people who most need them. Unitaid’s work allows large-scale introduction of health products through funding by governments, the Global Fund, and bilateral programs such as the United States President’s   Emergency Plan for AIDS Relief (PEPFAR).

The full review, including recommendations, will be published by DFID in the coming weeks and will be available here.

View All News

Featured News

02 July 2020

ACT-Accelerator moves to expand access to dexamethasone for low- and middle-income countries for COVID-19 treatment

Read More

22 June 2020

£2.2m for Liverpool-led initiative to rapidly identify COVID-19 ‘game changing’ drugs

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.